Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Folic Acid Tablets (0.4 mg) for Reduction of Plasma Homocysteine in Hyperhomocysteinemia
CTR20252699Phase 2Active
- Sponsor
- Beijing Sili'an Pharmaceutical
- Start
- Jul 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of folic acid in hyperhomocysteinemia, sponsored by Beijing Sili'an Pharmaceutical. Started Jul 2025; status: active.
02
Drugs
folic acid
03
Conditions
hyperhomocysteinemia
Beyond the preview
Go deeper on CTR20252699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252699.